Table 5 Correlation of ESRD and mortality outcomes with demographic, clinical and histopathological characteristics

Age

-0.1

0.27

0.008

0.93

Gender

-0.06

0.53

0.1

0.3

HTN

0.43

< 0.001

0.23

0.018

Edema

0.3

0.003

0.28

0.004

Hemoptysis

0.36

< 0.001

0.58

< 0.001

Oliguria

0.58

< 0.001

0.41

< 0.001

Creatinine at presentation

0.58

< 0.001

0.33

0.001

GFR at presentation

-0.6

< 0.001

-0.29

0.003

Need for HD at presentation

0.66

< 0.001

0.32

0.001

Hb

-0.66

< 0.001

-0.64

< 0.001

Albumin

-0.31

0.001

-0.34

< 0.001

Proteinuria

0.34

< 0.001

0.17

0.07

Number of sclerotic glomeruli

0.7

< 0.001

0.5

< 0.001

Number of crescentic glomeruli

-0.17

0.07

-0.09

0.37

Number of fibrous crescents

0.63

< 0.001

0.5

< 0.001

Number of cellular crescents

-0.49

< 0.001

-0.37

< 0.001

IFTA

0.64

< 0.001

0.38

< 0.001

Arteriosclerosis

0.71

< 0.001

0.37

< 0.001

Fibrinoid necrosis

0.29

0.004

0.24

0.016

TLO formation

0.38

< 0.001

0.37

< 0.001

Mesangial proliferation

0.43

< 0.001

0.3

0.003

Endocapillary proliferation

0.09

0.35

-0.07

0.43

Neutrophilic infiltration

0.26

0.008

0.21

0.03

Glomerular thrombosis

0.26

0.009

0.16

0.1

Infection

0.43

< 0.001

0.57

< 0.001

Respiratory failure

0.43

< 0.001

0.65

< 0.001

Heart failure

0.42

< 0.001

0.49

< 0.001

Diabetes mellitus

0.35

< 0.001

0.49

< 0.001